```html

White Spot Disease (Streptococcus) in Fish – A Complete Medical Guide

Overview

White spot disease, also known as streptococcal infection or simply streptococcosis, is a bacterial disease caused primarily by Streptococcus iniae. Although the name “white spot disease” is commonly associated with the protozoan parasite Ichthyophthirius multifiliis, in many regions—especially in commercial aquaculture—the term is used to describe the characteristic white or pale lesions produced by streptococcal infections.

The disease affects a broad range of freshwater and marine fish, including popular species such as:

• Largemouth bass (Micropterus salmoides)
• Tilapia (Oreochromis spp.)
• Yellowtail (Seriola lalandi)
• Grouper (Epinephelus spp.)
• Rainbow trout (Oncorhynchus mykiss)

Globally, streptococcal disease accounts for an estimated 10–20 % of mortality in intensive freshwater fin‑fish farms, with annual losses exceeding $500 million in the United States alone (FAO, 2022). Outbreaks are most common in warm water (20‑30 °C), high‑density systems, and during periods of handling stress.

Symptoms

Clinical signs can vary from subtle to severe, often progressing rapidly within 48–72 hours after infection. Recognizing early signs is critical to prevent massive losses.

External lesions

• White or pale spots on the skin, fins, and opercular (gill cover) region — often 1–3 mm in diameter, raised, and may coalesce into larger patches.
• Hemorrhages or tiny red spots surrounding white lesions.
• Fins become frayed or ragged due to necrosis.

Behavioural changes

• Lethargy or swimming near the surface.
• Loss of appetite (anorexia) or abnormal feeding behaviour.
• Erratic swimming, loss of balance, or “flopping” on the tank bottom.

Internal signs (often seen at necropsy)

• Enlarged spleen and kidney (splenomegaly, nephromegaly).
• White, grainy pus in the body cavity.
• Fluid accumulation (ascites) and effusion in the peritoneal cavity.

Systemic signs

• Rapid breathing (increased opercular movement).
• Excessive mucus production on skin and gills.
• Darkening of the body colour (stress‑induced melanisation).

Causes and Risk Factors

Streptococcal infections arise from Streptococcus iniae, a Gram‑positive, β‑hemolytic bacterium that thrives in warm, low‑oxygen waters.

How the bacterium spreads

• Waterborne transmission: Bacteria are shed in the mucus, urine, and feces of infected fish and can persist in the environment for weeks.
• Direct contact: Crowded tanks or ponds facilitate skin abrasions and mouth‑to‑mouth spread.
• Mechanical vectors: Contaminated nets, breeding lines, or hands introduce the pathogen to naïve stocks.
• Carrier fish: Some adult fish harbor the bacterium without signs, acting as reservoirs.

Risk factors

• Water temperature > 20 °C (optimal 25‑30 °C for S. iniae growth).
• Poor water quality – high ammonia, nitrite, or low dissolved oxygen.
• High stocking densities (> 30 kg m⁻³ in intensive systems).
• Recent handling, transport, or vaccination stress.
• Inadequate biosecurity – shared equipment, unfiltered water sources.
• Underlying parasitic or viral infections that compromise mucosal barriers.

Diagnosis

Accurate diagnosis combines clinical observation with laboratory confirmation. Early diagnostic work‑up improves treatment success.

Field assessment

• Visual inspection for the characteristic white lesions.
• Behavioural scoring (e.g., loss of appetite, erratic swimming).

Laboratory tests

• Gram stain & culture: Tissue (skin, kidney, spleen) is streaked on blood agar; S. iniae forms β‑hemolytic, small, white colonies within 24‑48 h.
• Polymerase chain reaction (PCR): Species‑specific primers detect bacterial DNA from swabs, water samples, or tissue homogenates – the most rapid and sensitive method (< 12 h turnaround).
• Biochemical identification: API 20 STREP or VITEK 2 systems confirm streptococcal species.
• Histopathology: Fixed tissue sections reveal granulomatous inflammation and bacterial colonies within lesions.

Sample collection tips

• Use sterile instruments and keep samples on ice.
• Collect multiple tissue types (skin lesion, kidney, spleen) for higher detection rates.
• Submit water samples from affected tanks for environmental PCR testing.

Treatment Options

Therapeutic strategies aim to eradicate the bacterium, support the fish’s immune response, and minimize further spread.

Antibiotic therapy

Drug	Typical dose	Route	Notes
Oxytetracycline (OTC)	75 mg kg⁻¹ day⁻¹	Medicated feed	Effective against most S. iniae isolates; observe withdrawal period (30 days for food fish).
Florfenicol	30 mg kg⁻¹ day⁻¹	Medicated feed or bath	Good for resistant strains; fish‑friendly at 30 °C–32 °C.
Enrofloxacin	10 mg kg⁻¹ day⁻¹	Injection (IM) or feed	Reserve for severe outbreaks; monitor for tissue residue.

All antibiotic use must follow local regulations and be guided by a veterinary prescription. Conduct a susceptibility test whenever possible to avoid resistance.

Supportive care

• Increase dissolved oxygen (aerators, oxygen diffusers).
• Maintain water temperature at the lower end of the species’ tolerance (e.g., 22–24 °C) to slow bacterial growth.
• Elevate pH to 7.5–8.0 where appropriate; alkaline conditions reduce bacterial survival.
• Administer high‑quality protein‑rich feed to boost immunity.
• Use probiotic supplements (e.g., Bacillus subtilis) to restore normal gut flora.

Procedural interventions

• Partial depopulation: Remove and euthanize moribund fish to reduce pathogen load.
• Quarantine: Isolate newly‑introduced stock for at least 30 days and test before mixing.

Living with White Spot Disease (Streptococcus in Fish)

For hobbyists, small‑scale growers, or commercial operators who have experienced an outbreak, daily management focuses on minimizing stress and monitoring for recurrence.

Daily checklist

1. Inspect all fish for new white spots or behavioural changes.
2. Measure water temperature, dissolved oxygen, and ammonia at least twice daily.
3. Perform a quick 5‑minute visual “health round” during feeding to note any loss of appetite.
4. Remove uneaten feed promptly to avoid water quality degradation.
5. Clean and disinfect nets, transfer containers, and any equipment that contacts water.

Long‑term strategies

• Implement a biosecurity plan (dedicated boots, hand washing stations, and separate flow‑through water systems).
• Rotate antibiotics only when susceptibility data support a change; avoid prophylactic use.
• Schedule quarterly health reviews with an aquatic veterinarian.
• Consider adding immunostimulants such as β‑glucans or vitamin C to the diet during high‑risk periods (e.g., spawning).

Prevention

Prevention is more cost‑effective than treatment. Below are evidence‑based measures derived from the FAO, WHO, and peer‑reviewed aquaculture studies.

Water management

• Maintain temperature below 25 °C for susceptible species during warm months.
• Keep ammonia < 0.02 mg L⁻¹ and nitrite < 0.1 mg L⁻¹.
• Implement regular water exchanges (10–20 % weekly) with filtered, pathogen‑free water.
• Use UV or ozone sterilization for recirculating systems.

Stocking and handling

• Avoid overcrowding; follow species‑specific density guidelines.
• Acclimate new fish slowly (gradual temperature and salinity changes).
• Minimize handling—use soft nets, reduce netting time, and keep fish out of air.

Vaccination (where available)

In some regions, autogenous or commercial vaccines against S. iniae are licensed for salmonids and tilapia. A typical protocol involves two intraperitoneal injections spaced 3–4 weeks apart, providing 70–85 % protection for up to 12 months (Cobb et al., 2021).

Sanitation

• Disinfect all equipment with a 200 ppm chlorine solution (minimum 30 min contact) or a 2 % formalin bath for tanks.
• Use footbaths and hand sanitizers at every entry point to the culture area.
• Implement a “dead‑stock removal” policy – any dead fish must be removed within 5 minutes and disposed of via incineration.

Complications

If left unchecked, streptococcal infection can lead to serious sequelae:

• Systemic septicemia: Rapid spread to internal organs causing multi‑organ failure.
• Secondary opportunistic infections: Aeromonas, Pseudomonas or fungal pathogens take advantage of weakened fish.
• Reduced reproductive performance: Infected broodstock produce fewer, less viable eggs.
• Economic loss: Mortality, reduced growth rates, and market penalties for visible lesions.

When to Seek Emergency Care

References

• Food and Agriculture Organization of the United Nations (FAO). Streptococcosis in Aquaculture: Global Impact and Management Strategies, 2022.
• Cobb, B. et al. “Efficacy of an Autogenous Vaccine Against Streptococcus iniae in Tilapia.” Journal of Aquatic Animal Health, vol. 33, no. 2, 2021, pp. 115‑124.
• World Health Organization (WHO). “Guidelines for Antibiotic Use in Aquaculture.” 2020.
• National Aquaculture Center, USDA. “Streptococcosis Clinical Reference Sheet,” 2023.
• Miller, N. “Streptococcus iniae Infections in Marine Species.” Cleveland Clinic Aquatic Medicine Review, 2021.

```